Literature DB >> 1697040

Central nervous system function in systemic lupus erythematosus.

K Elkon1, H Weissbach, N Brot.   

Abstract

Autoantibodies to three eukaryotic 60S ribosomal phosphoproteins P0, P1 and P2 have been found in the sera of 10-20% of patients with systemic lupus erythematosus (SLE). These antibodies inhibit protein synthesis in vitro and when microinjected into cultured human fibroblasts. The three proteins share a common epitope contained within the carboxyl terminal 22 amino acids of each protein. Because a significant number of SLE patients have central nervous system disturbances with major behavioral disorders, the antiribosomal protein autoantibodies were measured in this subset of SLE individuals to determine whether or not there was an association. These antibodies are present in 90% of SLE patients who were diagnosed as having psychosis, secondary to the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697040     DOI: 10.1007/bf00969925

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Antibodies reactive with neurons in SLE patients with neuropsychiatric manifestations.

Authors:  F P Quismorio; G J Friou
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

Review 2.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

3.  Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies.

Authors:  W T Butler; J T Sharp; R D Rossen; M D Lidsky; K K Mittal; D A Gard
Journal:  Arthritis Rheum       Date:  1972 May-Jun

4.  Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

Authors:  H A Wilson; J B Winfield; R G Lahita; D Koffler
Journal:  Arthritis Rheum       Date:  1979-05

5.  An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus.

Authors:  B Bresnihan; M Oliver; B Williams; G R Hughes
Journal:  Arthritis Rheum       Date:  1979-04

6.  Antiserum to brain gangliosides produces recurrent epileptiform activity.

Authors:  S E Karpiak; L Graf; M M Rapport
Journal:  Science       Date:  1976-11-12       Impact factor: 47.728

7.  Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors:  C Krishnan; M H Kaplan
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

8.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

9.  Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; G W Williams; A D Steinberg
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  2 in total

1.  An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.

Authors:  Julia Y Wang; Wei Zhang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-02-22

2.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.